Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Japan Lifeline Co's 9-Day RSI or its related term are showing as below:
FRA:L8B's 9-Day RSI is ranked worse than 73.99% of 869
companies
in the Medical Devices & Instruments industry
Industry Median: 49.94
vs FRA:L8B: 58.48
Japan Lifeline Co (FRA:L8B) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Japan Lifeline Co 9-Day RSI Related Terms
FRA:L8B vs ABT, SYK, MDT: 9-Day RSI Comparison
For the Medical Devices subindustry, Japan Lifeline Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co 9-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Lifeline Co (FRA:L8B) has a 9-Day RSI of 58.48 as of Jul. 18, 2026. According to the industry distribution chart, Japan Lifeline Co ranks #643 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 74%.
Is Japan Lifeline Co's 9-Day RSI too high?
Japan Lifeline Co's current 9-Day RSI is 58.48. The Medical Devices & Instruments industry median 9-Day RSI is 49.94. Japan Lifeline Co's value of 58.48 is 17.1% above this industry median. Based on the distribution chart, Japan Lifeline Co ranks #643 out of 869 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Japan Lifeline Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's 9-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #643 out of 869 companies for 9-Day RSI. This places Japan Lifeline Co in the lower half of its industry. The industry median 9-Day RSI is 49.94. Japan Lifeline Co's value of 58.48 is 17.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Devices & Instruments company?
The median 9-Day RSI among Medical Devices & Instruments companies is 49.94, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current 9-Day RSI of 58.48 is 17.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 9-Day RSI is 49.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current 9-Day RSI is 58.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Japan Lifeline Co (FRA:L8B) has a current 9-Day RSI of 58.48. The stock's GF Value™ is €8.11, compared to a current price of €7.20 — trading 11.2% below its estimated fair value. The current 9-Day RSI is 58.48 and 17.1% above the Medical Devices & Instruments industry median of 49.94. Japan Lifeline Co's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Japan Lifeline Co (FRA:L8B), the current 9-Day RSI is 58.48 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (FRA:L8B) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of €7.20 is trading 11.2% below its estimated GF Value™ of €8.11.
Key valuation signals for FRA:L8B:
9-Day RSI: 58.48
GF Value™: €8.11 vs. price of €7.20 (11.2% below fair value)
Industry Position: 17.1% above the Medical Devices & Instruments median (#643 of 869)
No single metric tells the full story. See the FRA:L8B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
84GF Score
Get the complete analysis for FRA:L8B
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L8B has been successfully added to your 
